Skip to the rundown
GetYourBrief Biotech desk · week of Feb 23
Search

Week brief · February 23 to March 1, 2026

Biotech news, week of February 23, 2026

In the week of February 23 to March 1, 2026 the Biotech desk recorded 9 news events on 4 days. Pharma led with 5.

The most covered stories of the week

  1. Feb 24 TED Audacious Project raises $1B from donors in 2 days 2
  2. Feb 25 Kennedy Jr. on safety profiles of vaccines, acetaminophen, and antidepressants 2
  3. Feb 25 Fund reveals $170 million exit from Protagonist, report says 2
  4. Feb 25 benzinga.com: “Insights into Ginkgo Bioworks Holdings Upcoming Earnings - Ginkgo Bioworks Holdings (NYSE: DNA)” 1
  5. Feb 26 Neurizon begins dosing NUZ-001 in HEALEY ALS platform trial 1
  6. Feb 27 insidermonkey.com: “Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q4 2025 Earnings Call Transcript” 1

Tuesday, February 24, 2026

  1. 01

    TED Audacious Project raises $1B from donors in 2 days

    2 outlets · first: dailygazette.com Funding

    Reported by dailygazette.com and kob.com.

    • TED Audacious Project
    • TED

    Full coverage: every report, when each was published, and who was named (2 outlets)

Wednesday, February 25, 2026

  1. 02

    Kennedy Jr. on safety profiles of vaccines, acetaminophen, and antidepressants

    2 outlets · first: nbclosangeles.com Pharma

    Machine summary Kennedy Jr. regarding the safety profiles of vaccines, acetaminophen, and antidepressants.

    Reported by nbclosangeles.com and nbcsandiego.com.

  2. 03

    Fund reveals $170 million exit from Protagonist, report says

    2 outlets · first: fool.com Pharma

    Machine summary A fund revealed a $170 million exit from Protagonist, according to a report. The report also states that Protagonist stock is up 120%.

    1. Protagonist stock is up 120%, according to the report.

    Reported by fool.com and finance.yahoo.com.

  3. 04

    Coverage recordbenzinga.com: “Insights into Ginkgo Bioworks Holdings Upcoming Earnings - Ginkgo Bioworks Holdings (NYSE: DNA)”

    1 outlet · first: Benzinga Pharma

    The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

    Reported by Benzinga.

    • Ginkgo Bioworks
    • Ginkgo Bioworks Holdings

Thursday, February 26, 2026

  1. 05

    Neurizon begins dosing NUZ-001 in HEALEY ALS platform trial

    1 outlet · first: malaysiasun.com (Big News Network) Clinical trial

    Machine summary Neurizon has initiated dosing of NUZ-001 in the HEALEY ALS Platform Trial, according to reports.

    1. Neurizon initiated dosing of NUZ-001 in the HEALEY ALS Platform Trial, according to reports.

    Reported by malaysiasun.com (Big News Network) and sydneysun.com (Big News Network).

Friday, February 27, 2026

  1. 06

    Coverage recordinsidermonkey.com: “Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q4 2025 Earnings Call Transcript”

    1 outlet · first: Insider Monkey Pharma

    The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

    Reported by Insider Monkey.

More events reported

No summary of ours and no outlet headline passed our automated checks for these, which says nothing about the events (how they work); the outlets and their reports are linked.

Tuesday, February 24, 2026

  1. · 2 outletswsiu.org, klcc.org

Thursday, February 26, 2026

  1. · 1 outlettheprovince.com
  2. · 2 outletsInsider Monkey, finance.yahoo.comNamed in the reports: RBC Capital

Summaries and key facts are machine summaries of the reports linked with them; outlets, times and counts come from those reports. How a rundown is built.

What kind of news was it?

  1. Pharma 5
  2. Gene therapy 2
  3. Funding 1
  4. Clinical trial 1

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).